{
  "ptid_time": "133_S_1031_2006-10-31",
  "img_path": "/data/qiuhui/data/adni/images/133_S_1031/2006-10-31/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 52,019 mm³, 85.3% above the reference mean. With a Z-score of 1.95 (97.5th percentile), this represents moderate enlargement; hippocampal volume measures 4,628 mm³, 35.0% below the reference mean. With a Z-score of -3.21 (0.1th percentile), this represents profound atrophy; whole brain volume measures 863,619 mm³, 11.4% below the reference mean. With a Z-score of -1.43 (7.6th percentile), this represents mild atrophy; entorhinal cortex volume measures 1,760 mm³, 52.1% below the reference mean. With a Z-score of -3.20 (0.1th percentile), this represents profound atrophy; fusiform gyrus volume measures 16,308 mm³, 4.1% below the reference mean. With a Z-score of -0.38 (35.3th percentile), this represents normal volume ; middle temporal gyrus volume measures 14,779 mm³, 22.9% below the reference mean. With a Z-score of -1.99 (2.3th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 77.1 years. Gender is Female. Education: 18 years. Handedness: Right. Race: White. Medical history: Psychiatric; Cardiovascular; Respiratory; Musculoskeletal; Endocrine-Metabolic; Renal-Genitourinary; Smoking; Major Surgical Procedures. MMSE: 29.0. Logical Memory: 8.0. APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows profound atrophy in the hippocampus and entorhinal cortex, which are key regions affected in Alzheimer's disease (AD), along with moderate ventricular enlargement and mild-to-moderate atrophy in other temporal regions. However, the MMSE score of 29 is within the normal range, and the absence of APOE4 reduces genetic risk. This discrepancy between structural changes and preserved cognition suggests early neurodegeneration without significant clinical impairment.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amnestic subtype given hippocampal/entorhinal atrophy)  \n**Confidence:** **Medium** (High confidence in neurodegeneration, but MCI diagnosis is tentative due to the normal MMSE; clinical correlation with more sensitive cognitive tests, such as the MoCA or episodic memory assessments, would strengthen certainty).  \n\n*Note:* If follow-up testing reveals subtle memory deficits, progression to AD dementia is highly likely given the atrophy pattern. If cognition remains intact, this could represent preclinical AD or another tauopathy. Biomarkers (e.g., CSF Aβ42/tau or amyloid PET) would help clarify.",
  "timestamp": "2025-07-26T15:29:05.946378"
}